Verma S, Sharma A, Zinman B, Ofstad AP, et al. Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes Obes Metab 2020 Mar 29. doi: 10.1111/dom.14015.
PMID: 32227432